Geographical differences in the ratio of percutaneous and surgical myocardial revascularization procedures in the treatment of coronary artery disease.
Piccolo, Raffaele; Windecker, Stephan; Kolh, Philippe
2017 • In European Journal of Cardio-Thoracic Surgery, 52 (3), p. 454-455
Kolh, Philippe ; Université de Liège - ULiège > Département des sciences biomédicales et précliniques > Biochimie et physiologie générales, humaines et path.
Language :
English
Title :
Geographical differences in the ratio of percutaneous and surgical myocardial revascularization procedures in the treatment of coronary artery disease.
Piccolo R, Giustino G, Mehran R, Windecker S. Stable coronary artery disease: revascularisation and invasive strategies. Lancet 2015;386: 702-13.
Pitt B, Pfeffer MA, Assmann SF, Boineau R, Anand IS, Claggett B et al. Spironolactone for heart failure with preserved ejection fraction. N Engl J Med 2014;370:1383-92.
Pfeffer MA, Claggett B, Assmann SF, Boineau R, Anand IS, Clausell N et al. Regional variation in patients and outcomes in the Treatment of Preserved Cardiac Function Heart Failure With an Aldosterone Antagonist (TOPCAT) trial. Circulation 2015;131:34-42.
de Denus S, O'Meara E, Desai AS, Claggett B, Lewis EF, Leclair G et al. Spironolactone metabolites in TOPCAT-new insights into regional variation. N Engl J Med 2017;376:1690-2.
Milojevic M, Head SJ, Mack MJ, Mohr FW, Morice MC, Dawkins KD et al. Influence of practice patterns on outcome among countries enrolled in the SYNTAX trial: 5-year results between percutaneous coronary intervention and coronary artery bypass grafting. Eur J Cardiothorac Surg 2017;52:445-53.
Yusuf S, Wittes J. Interpreting geographic variations in results of randomized, controlled trials. N Engl J Med 2016;375:2263-71.
